US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Defiance Daily Target 2X Long NVO ETF

9.54

+0.36003.92%

Pre-market: 9.23-0.3100-3.25%06:44 EDT

Volume:948.63K

Turnover:8.96M

Market Cap:39.95M

PE:- -

High:9.65

Open:9.22

Low:9.19

Close:9.18

52wk High:33.81

52wk Low:8.87

Shares:4.19M

Float Shares:4.19M

Volume Ratio:1.56

T/O Rate:22.65%

Dividend:- -

Dividend Rate:- -

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Cboe data suggests bullish flow in Novo Nordisk with shares up 1.69%

Novo Nordisk A/S Series B Stock Rises Wednesday, Outperforms Market

Novo Nordisk call volume above normal and directionally bullish

European Equities Traded in US as ADRs Fall in Wednesday Trading

MT Newswires Live

Deutsche Bank Keeps Their Sell Rating on Novo Nordisk (0QIU)

Why Vaxcyte Chose A 1.5% Convertible

Novo Nordisk Probes Patient Priorities in German Hemophilia A Study

From Lilly Deal to Market Darling: Inside Ginkgo's 120% Monthly Run

Bellwether Stocks Movement

Cboe data shows mixed options sentiment in Novo Nordisk with shares down 0.47%

Novo Nordisk A/S Series B Stock Falls Monday, Underperforms Market

J.P. Morgan Sticks to Their Hold Rating for Novo Nordisk (0QIU)

Novo Nordisk Could Raise Guidance Alongside Strong Results

Merck Doubled Off Its Lows — And Analysts Still See More Room

Bellwether Stocks Movement

CSL Bets $1.6 Billion on a Drug That Hasn't Finished Phase 2

Bellwether Stocks Movement

One Weekend, Thousands Of Compounds: Inside Microsoft's New AI Biology Model

AI Industry Frontlines

Bayer Bets $2.2 Billion That America Is Still The Best Place To Make Drugs

23.3% Vs 14.8%: Lilly's New Data Just Changed The Obesity Drug Playbook

Bellwether Stocks Movement

Novo Nordisk Says FDA Review of Hemophilia Drug is Hitting Delays

Novo Nordisk Tests Zenagamtide Dosing to Sharpen Its Obesity Drug Pipeline

Novo Nordisk A/S Series B Stock Falls Friday, Underperforms Market

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.tigrgood.cn/stock/NVOX/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"NVOX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NVOX\",,,,,undefined,":{"symbol":"NVOX","market":"US","secType":"STK","nameCN":"Defiance Daily Target 2X Long NVO ETF","latestPrice":9.54,"timestamp":1791403200000,"preClose":9.18,"halted":0,"volume":948628,"hourTrading":{"tag":"盘前","latestPrice":9.23,"preClose":9.54,"latestTime":"06:44 EDT","volume":7001,"amount":65619.721907,"timestamp":1791456267837,"change":-0.31,"changeRate":-0.032495,"amplitude":0.01782},"delay":0,"changeRate":0.03921568627450974,"floatShares":4188101,"shares":4188101,"eps":0,"marketStatus":"Pre-Mkt","change":0.36,"latestTime":"10-08 06:47:08 EDT","open":9.215,"high":9.65,"low":9.185,"amount":8962690.467168,"amplitude":0.050654,"askPrice":9.3,"askSize":3710,"bidPrice":9.27,"bidSize":3180,"shortable":3,"etf":2,"ttmEps":0,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1791466200000},"marketStatusCode":1,"adr":0,"exchange":"ARCA","adjPreClose":9.54,"sharesOutstanding":4098101,"nav":9.2,"aum":38530529.2,"bidAskSpread":0,"preHourTrading":{"tag":"盘前","latestPrice":9.23,"preClose":9.54,"latestTime":"06:44 EDT","volume":7001,"amount":65619.721907,"timestamp":1791456267837,"change":-0.31,"changeRate":-0.032495,"amplitude":0.01782},"postHourTrading":{"tag":"盘后","latestPrice":9.58,"preClose":9.54,"latestTime":"19:59 EDT","volume":4634,"amount":44244.1202,"timestamp":1791417588867,"change":0.04,"changeRate":0.004193,"amplitude":0.006289},"volumeRatio":1.5647546026187282,"impliedVol":0.6848,"impliedVolPercentile":0.2771},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NVOX\",,,,,undefined,":{"symbol":"NVOX","floatShares":4188101,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":1.5647546026187282,"shares":4188101,"dividePrice":0,"high":9.65,"amplitude":0.050654,"preClose":9.18,"low":9.185,"week52Low":8.87,"pbRate":"--","week52High":33.81,"institutionHeld":0,"latestPrice":9.54,"committee":-0.076923,"eps":0,"divideRate":0,"volume":948628,"delay":0,"ttmEps":0,"open":9.215,"prevYearClose":21.89,"prevWeekClose":9.1,"prevMonthClose":9.41,"prevQuarterClose":9.41,"fiveDayClose":9.41,"twentyDayClose":13.3,"sixtyDayClose":16.69},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/NVOX\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-12-09","symbol":"NVOX","defaultRemindTime":1765290600000,"type":"split","dateTimestamp":1765256400000,"forFactor":8,"toFactor":1,"ratio":8}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"NVOX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"NVOX\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"NVOX\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2673301492","title":"Cboe data suggests bullish flow in Novo Nordisk with shares up 1.69%","url":"https://stock-news.laohu8.com/highlight/detail?id=2673301492","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673301492?lang=en_us&edition=fundamental","pubTime":"2026-10-08 01:00","pubTimestamp":1791392420,"startTime":"0","endTime":"0","summary":"Cboe data suggests bullish flow in Novo Nordisk (NVO), with shares up 64c, or 1.69%, near $38.16. Options volume roughly in line with average with ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/cboe-data-suggests-bullish-flow-in-novo-nordisk-with-shares-up-1-69-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/cboe-data-suggests-bullish-flow-in-novo-nordisk-with-shares-up-1-69-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NVOC","THNR","BK4588","BK4585","NVOX","NVO","NVOH","LU1093756325.SGD","OZEM","IE00BKVL7J92.USD","IE00BZ1G4Q59.USD","BK4007","LU0154236417.USD","BK4532","BK4599","PPH","LU1093756168.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673116150","title":"Novo Nordisk A/S Series B Stock Rises Wednesday, Outperforms Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2673116150","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673116150?lang=en_us&edition=fundamental","pubTime":"2026-10-08 00:03","pubTimestamp":1791388980,"startTime":"0","endTime":"0","summary":"This article was automatically generated using Dow Jones technology.Shares of Novo Nordisk A/S Series B advanced 3.4% to DKK253.90 Wednesday on what proved to be an overall unfavorable trading session for the stock market, with the OMX Nordic 40 Index falling 0.8% to 2,598.33.The stock's rise  snapped a four-day losing streak.The company closed DKK156.05 short of its 52-week high of DKK409.95, which the company achieved on January 23, 2026.Trading volume was 6,162,474, compared to the 50-day average trading volume of 5,007,609.Data source: Dow Jones Market Data, FactSet","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0154236417.USD","NVOX","NVOH","OZEM","IE00BZ1G4Q59.USD","BK4532","BK4585","BK4588","BK4599","BK4007","LU1093756325.SGD","NVO","PPH","THNR","NVOC","IE00BKVL7J92.USD","LU1093756168.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673115990","title":"Novo Nordisk call volume above normal and directionally bullish","url":"https://stock-news.laohu8.com/highlight/detail?id=2673115990","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673115990?lang=en_us&edition=fundamental","pubTime":"2026-10-07 23:45","pubTimestamp":1791387913,"startTime":"0","endTime":"0","summary":"Bullish option flow detected in Novo Nordisk (NVO) with 26,441 calls trading, 1.5x expected, and implied vol increasing over 1 point to 41.74%. Jan...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/novo-nordisk-call-volume-above-normal-and-directionally-bullish-thefly-news-4?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/novo-nordisk-call-volume-above-normal-and-directionally-bullish-thefly-news-4?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE00BKVL7J92.USD","BK4585","BK4532","OZEM","BK4599","LU1093756168.USD","NVOX","IE00BZ1G4Q59.USD","BK4007","LU1093756325.SGD","NVOC","PPH","LU0154236417.USD","NVO","THNR","NVOH","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673301969","title":"European Equities Traded in US as ADRs Fall in Wednesday Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2673301969","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673301969?lang=en_us&edition=fundamental","pubTime":"2026-10-07 23:09","pubTimestamp":1791385793,"startTime":"0","endTime":"0","summary":"European equities traded in the US as American depositary receipts fell late Wednesday morning with the S&P Europe Select ADR Index declining 1.2% to 1,875.05.From continental Europe, the gainers were led by medical device maker EDAP TMS  and pharmaceutical company Sanofi , which increased 3% and 0.8%, respectively. They were followed by pharmaceutical company Novo Nordisk  and biopharmaceutical company argenx , which were up 0.6% and 0.4%, respectively.The decliners from continental Europe were led by lender Banco Bilbao Vizcaya Argentaria  and biopharmaceutical company Cellectis , which decreased 3.9% and 3.6%, respectively. They were followed by lenders Banco Santander  and ING , which dropped 3.3% and 3.2%, respectively.The gainers from the UK were led by biopharmaceutical companies NuCana  and Mereo BioPharma Group , which advanced 3.8% and 3.3%, respectively. They were followed by telecommunications operator Vodafone Group  and tobacco company British American Tobacco , which ros","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IE0009355771.USD","IE0034235188.USD","IE00BFXG1179.USD","LU0109394709.USD","LU2324357040.USD","LU0006061336.USD","CLLS","TBXU","LU0310800965.SGD","BK4162","BDRX","BK4207","LU0162691827.USD","LU2236285917.USD","FOCL","LU0211326839.USD","BK4585","LU1093756168.USD","LU0496365809.HKD","BK4132","TRIB","BK4521","LU1093756325.SGD","IE00BKVL7J92.USD","LU1267930227.SGD","GSIB","BK4075","BK4082","ING","LU0823416689.USD","ARGX","IE0002141913.USD","NICO","BK4139","BTI","PUK","IBB","NVO","FMED","LU0211326755.USD","BK4588","BK4532","02378","MREO","IE00BZ1G4Q59.USD","BK4599","LU0889565916.HKD","THNR","LU0976567544.SGD","IE00BJJMRZ35.SGD","NCNA","OZEM","LU2543165471.USD","PPH","LU0128525689.USD","LU0390134368.USD","IE00BJT1NW94.SGD","LU0072461881.USD","HSBC","HSBH","SAN","LU0052756011.USD","LU1983260115.SGD","LU0320765992.SGD","00005","IE00B4R5TH58.HKD","BBVA","SNY","VOD","NVOX","NVOH","IE00B2B36J28.USD","LU0154236417.USD","BK4007","IE00BFTCPJ56.SGD","BK4505","NVOC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673096639","title":"Deutsche Bank  Keeps Their Sell Rating on Novo Nordisk (0QIU)","url":"https://stock-news.laohu8.com/highlight/detail?id=2673096639","media":"TIPRANKS","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673096639?lang=en_us&edition=fundamental","pubTime":"2026-10-07 15:58","pubTimestamp":1791359924,"startTime":"0","endTime":"0","summary":"In a report released today, Emmanuel Papadakis from Deutsche Bank maintained a Sell rating on Novo Nordisk, with a price target of DKK225.00. Accor...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/deutsche-bank-keeps-their-sell-rating-on-novo-nordisk-0qiu-blurbs-news-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/deutsche-bank-keeps-their-sell-rating-on-novo-nordisk-0qiu-blurbs-news-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4532","BK4588","BK4599","LU0154236417.USD","PPH","OZEM","BK4007","BK4585","LU1093756325.SGD","THNR","IE00BZ1G4Q59.USD","LU1093756168.USD","NVOC","NVOX","NVO","NVOH","IE00BKVL7J92.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1179317192","title":"Why Vaxcyte Chose A 1.5% Convertible","url":"https://stock-news.laohu8.com/highlight/detail?id=1179317192","media":"Macro World","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1179317192?lang=en_us&edition=fundamental","pubTime":"2026-10-07 14:39","pubTimestamp":1791355173,"startTime":"0","endTime":"0","summary":"","market":"us","thumbnail":"https://news-video-sg.skytigris.cn/videos/covers/3223.webp","type":0,"news_type":0,"thumbnails":["https://news-video-sg.skytigris.cn/videos/covers/3223.webp"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AZN","BIIB","MRNX","MRNY","GSK","BNTX","NVO","NVAX","NVOH","PCVX","ABBV","ELIL","VERU","GILD","NVOX","REGN","NVOC","SNY","AMGN","GSKH","VIR","LLYX","MRK","LLII","LLY","PFE","ABT","ELIS","BMY","MRNA","NVS","JNJ"],"isVideo":true,"video":{"duration":118,"video_url":"https://news-video-sg.skytigris.cn/videos/cdn/3223.mp4","video_thumbnail":"https://news-video-sg.skytigris.cn/videos/covers/3223.webp","audio_url":"https://static.tigerbbs.com/a3b4d121da19466383da6687bb50a205.mp3","isAI":true},"gpt_icon":0},{"id":"2673050352","title":"Novo Nordisk Probes Patient Priorities in German Hemophilia A Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2673050352","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673050352?lang=en_us&edition=fundamental","pubTime":"2026-10-07 00:31","pubTimestamp":1791304305,"startTime":"0","endTime":"0","summary":"Novo Nordisk ($NVO) announced an update on their ongoing clinical study. Novo Nordisk Tests What Matters Most to Hemophilia A Patients in Germany. ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/novo-nordisk-probes-patient-priorities-in-german-hemophilia-a-study?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/novo-nordisk-probes-patient-priorities-in-german-hemophilia-a-study?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["THNR","BK4585","NVOX","BK4007","BK4532","OZEM","NVO","LU1093756325.SGD","LU1093756168.USD","BK4599","BK4588","IE00BZ1G4Q59.USD","NVOH","LU0154236417.USD","PPH","NVOC","IE00BKVL7J92.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1130787623","title":"From Lilly Deal to Market Darling: Inside Ginkgo's 120% Monthly Run","url":"https://stock-news.laohu8.com/highlight/detail?id=1130787623","media":"Bellwether Stocks Movement","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1130787623?lang=en_us&edition=fundamental","pubTime":"2026-10-06 10:42","pubTimestamp":1791254527,"startTime":"0","endTime":"0","summary":"","market":"other","thumbnail":"https://news-video-sg.skytigris.cn/videos/covers/3157.webp","type":0,"news_type":0,"thumbnails":["https://news-video-sg.skytigris.cn/videos/covers/3157.webp"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"From Lilly Deal to Market Darling: Inside Ginkgo's 120% Monthly Run","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ELIL","ABT","GSK","JNJ","MRK","MRNX","ABBV","BMY","GERM","IDNA","LLYX","VIR","GILD","AZN","NVOX","SBIO","DNA","PFE","SNY","NVAX","XBI","BIIB","NVOH","LLY","VERU","BNTX","LLII","MRNY","REGN","NVO","ELIS","AMGN","MRNA","NVS","GSKH","NVOC"],"isVideo":true,"video":{"duration":153,"video_url":"https://news-video-sg.skytigris.cn/videos/cdn/3157.mp4","video_thumbnail":"https://news-video-sg.skytigris.cn/videos/covers/3157.webp","audio_url":"https://static.tigerbbs.com/bf2704fcb2c9a829b788528d676b3500.mp3","isAI":true},"gpt_icon":0},{"id":"2673086789","title":"Cboe data shows mixed options sentiment in Novo Nordisk with shares down 0.47%","url":"https://stock-news.laohu8.com/highlight/detail?id=2673086789","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673086789?lang=en_us&edition=fundamental","pubTime":"2026-10-06 01:15","pubTimestamp":1791220511,"startTime":"0","endTime":"0","summary":"Cboe data shows mixed options sentiment in Novo Nordisk (NVO), with shares down 18c near $37.15. Options volume relatively light with 24k contracts...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/cboe-data-shows-mixed-options-sentiment-in-novo-nordisk-with-shares-down-0-47-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/cboe-data-shows-mixed-options-sentiment-in-novo-nordisk-with-shares-down-0-47-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4599","PPH","BK4585","LU0154236417.USD","LU1093756168.USD","NVOX","BK4532","LU1093756325.SGD","NVOC","IE00BZ1G4Q59.USD","NVOH","OZEM","THNR","BK4007","NVO","BK4588","IE00BKVL7J92.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673085403","title":"Novo Nordisk A/S Series B Stock Falls Monday, Underperforms Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2673085403","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673085403?lang=en_us&edition=fundamental","pubTime":"2026-10-06 00:03","pubTimestamp":1791216180,"startTime":"0","endTime":"0","summary":"This article was automatically generated using Dow Jones technology.Shares of Novo Nordisk A/S Series B shed 0.8% to DKK246.80 Monday on what proved to be an overall mediocre trading session for the stock market, with the OMX Nordic 40 Index holding steady at 2,595.90.This was the stock's third consecutive day of losses.The company closed DKK163.15 below its 52-week high of DKK409.95, which the company achieved on January 23, 2026.Trading volume was 5,784,986, compared to the 50-day average trading volume of 4,924,415.Data source: Dow Jones Market Data, FactSet","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1093756325.SGD","PPH","IE00BZ1G4Q59.USD","LU0154236417.USD","BK4588","THNR","LU1093756168.USD","NVO","BK4532","BK4585","BK4007","BK4599","NVOX","OZEM","NVOH","IE00BKVL7J92.USD","NVOC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673029387","title":"J.P. Morgan Sticks to Their Hold Rating for Novo Nordisk (0QIU)","url":"https://stock-news.laohu8.com/highlight/detail?id=2673029387","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673029387?lang=en_us&edition=fundamental","pubTime":"2026-10-05 19:56","pubTimestamp":1791201382,"startTime":"0","endTime":"0","summary":"In a report released today, Richard Vosser from J.P. Morgan maintained a Hold rating on Novo Nordisk, with a price target of DKK275.00. According t...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/j-p-morgan-sticks-to-their-hold-rating-for-novo-nordisk-0qiu-blurbs-news-3?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/j-p-morgan-sticks-to-their-hold-rating-for-novo-nordisk-0qiu-blurbs-news-3?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","BK4532","NVOX","OZEM","NVO","BK4585","IE00BKVL7J92.USD","NVOC","PPH","THNR","BK4599","BK4007","NVOH","LU0154236417.USD","LU1093756325.SGD","LU1093756168.USD","IE00BZ1G4Q59.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673415703","title":"Novo Nordisk Could Raise Guidance Alongside Strong Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2673415703","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673415703?lang=en_us&edition=fundamental","pubTime":"2026-10-05 16:03","pubTimestamp":1791187380,"startTime":"0","endTime":"0","summary":"0802 GMT - Novo Nordisk will likely report a strong set of third-quarter results and raise full-year guidance, J. P. Morgan analysts write. The bank forecasts adjusted sales of 76 billion Danish kroner, 4% ahead of Bloomberg consensus. It expects injectable Wegovy sales of 21.5 billion kroner, 9% ahead of consensus, reflecting continued growth in sales outside the U.S. Oral Wegovy sales are seen at 5.3 billion kroner, 19% ahead of views, as it says consensus seems to be underestimating sales outside the U.S. Ozempic sales are seen at 26.6 billion kroner, 7% ahead of consensus. Adjusted operating profit is seen at 30 billion kroner. The bank also expects Novo to raise its constant exchange rate guidance for adjusted sales and adjusted operating profit to minus 3% to plus 1%, from 0% to minus 6%. Shares fall 1.5%.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BKVL7J92.USD","BK4588","LU1093756325.SGD","BK4599","OZEM","THNR","NVO","NVOH","BK4007","NVOX","IE00BZ1G4Q59.USD","LU0154236417.USD","NVOC","PPH","BK4585","BK4532","LU1093756168.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1124786704","title":"Merck Doubled Off Its Lows — And Analysts Still See More Room","url":"https://stock-news.laohu8.com/highlight/detail?id=1124786704","media":"Bellwether Stocks Movement","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1124786704?lang=en_us&edition=fundamental","pubTime":"2026-10-05 14:41","pubTimestamp":1791182489,"startTime":"0","endTime":"0","summary":"","market":"other","thumbnail":"https://news-video-sg.skytigris.cn/videos/covers/3135.webp","type":0,"news_type":0,"thumbnails":["https://news-video-sg.skytigris.cn/videos/covers/3135.webp"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Merck Doubled Off Its Lows — And Analysts Still See More Room","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["YSPY",".DJI","DXD","JPMO","SPXS","SPY","GSK","SPYQ","IVV","SPYH","REGN","NVS","NVOH","TQQQ","ABT","JNJ","UDOW","HIBL","LLII","SPXL","UPRO","JPM","SQQQ",".IXIC","DDM","GILD","ELIL","SNY","VERU","SMAX","BIIB","AMGN","BMY","SSO","NVAX","SPYM","MRNA","MRNY","ABBV","PFE","SPUU","DMAX","SH","JPO","MMAX","SPYU","NVOX","QQQ","VIR","NVO","SDS","ELIS","AZN","VOO","SPDN","SPXU","NVOC","SDOW","BNTX","DIA","MRK","LLY","GSKH","LLYX","DOG","MRNX",".SPX"],"isVideo":true,"video":{"duration":182,"video_url":"https://news-video-sg.skytigris.cn/videos/cdn/3135.mp4","video_thumbnail":"https://news-video-sg.skytigris.cn/videos/covers/3135.webp","audio_url":"https://static.tigerbbs.com/d492d9882b1cd5d0c5306026a8f1963f.mp3","isAI":true},"gpt_icon":0},{"id":"1157208455","title":"CSL Bets $1.6 Billion on a Drug That Hasn't Finished Phase 2","url":"https://stock-news.laohu8.com/highlight/detail?id=1157208455","media":"Bellwether Stocks Movement","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1157208455?lang=en_us&edition=fundamental","pubTime":"2026-10-05 10:38","pubTimestamp":1791167898,"startTime":"0","endTime":"0","summary":"","market":"hk","thumbnail":"https://news-video-sg.skytigris.cn/videos/covers/3125.webp","type":0,"news_type":0,"thumbnails":["https://news-video-sg.skytigris.cn/videos/covers/3125.webp"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"CSL Bets $1.6 Billion on a Drug That Hasn't Finished Phase 2","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NVOH","REGN","NVOC","MRNY","JNJ","AMGN","CSLLY","ABBV","GSKH","ABT","NVOX","ELIL","LLYX","LLII","AZN","GSK","MRNA","NVO","BIIB","VIR","BNTX","NVS","NVAX","MRK","SNY","BMY","ELIS","VERU","LLY","GILD","MRNX","PFE"],"isVideo":true,"video":{"duration":229,"video_url":"https://news-video-sg.skytigris.cn/videos/cdn/3125.mp4","video_thumbnail":"https://news-video-sg.skytigris.cn/videos/covers/3125.webp","audio_url":"https://static.tigerbbs.com/c84a44b957cb1cda4f39d165f739b07a.mp3","isAI":true},"gpt_icon":0},{"id":"1181200013","title":"One Weekend, Thousands Of Compounds: Inside Microsoft's New AI Biology Model","url":"https://stock-news.laohu8.com/highlight/detail?id=1181200013","media":"AI Industry Frontlines","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1181200013?lang=en_us&edition=fundamental","pubTime":"2026-10-03 18:15","pubTimestamp":1791022548,"startTime":"0","endTime":"0","summary":"","market":"sg","thumbnail":"https://news-video-sg.skytigris.cn/videos/covers/3089.webp","type":0,"news_type":0,"thumbnails":["https://news-video-sg.skytigris.cn/videos/covers/3089.webp"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"One Weekend, Thousands Of Compounds: Inside Microsoft's New AI Biology Model","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NVD","NVDU","LLY","NVDG","NVII","MSFX","GOGL","AIQ","NVDO","MSFY","GOOGL","LLYX","GOOW","NVOH","GOOL","ARKG","GOOX","DIPS","GGLL","GOU","NVDW","NVDL","NVDQ","07388","MSFL","RXRX","NVDB","NVDY","ANV","NVDA","NVS","SDGR","GGLS","JNJ","NVDD","NVOX","LLII","GOOY","07788","NVYY","ELIL","ELIS","NVO","GOOP","MSFW","NVDX","NVOC","MSFD","MSFO","NVC","IBB","NVDS","MSFC","MSFT","MSFU"],"isVideo":true,"video":{"duration":212,"video_url":"https://news-video-sg.skytigris.cn/videos/remotion/3089/render_3089_1791021487749.mp4","video_thumbnail":"https://news-video-sg.skytigris.cn/videos/covers/3089.webp","audio_url":"https://news-video-sg.skytigris.cn/videos/remotion/3089/tts/voiceover_b9d2a6cae7d8b2cb.mp3","isAI":true},"gpt_icon":0},{"id":"1151971109","title":"Bayer Bets $2.2 Billion That America Is Still The Best Place To Make Drugs","url":"https://stock-news.laohu8.com/highlight/detail?id=1151971109","media":"Macro World","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1151971109?lang=en_us&edition=fundamental","pubTime":"2026-10-03 17:22","pubTimestamp":1791019366,"startTime":"0","endTime":"0","summary":"","market":"uk","thumbnail":"https://news-video-sg.skytigris.cn/videos/covers/3081.webp","type":0,"news_type":0,"thumbnails":["https://news-video-sg.skytigris.cn/videos/covers/3081.webp"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Bayer Bets $2.2 Billion That America Is Still The Best Place To Make Drugs","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NVOH","PFE","BIIB","GILD","NVS","VERU","ABBV","GSK","NVAX","MRNX","AZN","NVOC","VIR","ELIL","SNY","ABT","NVO","MRNY","BAYRY","BNTX","BMY","GSKH","NVOX","MRK","MRNA","LLYX","JNJ","AMGN","ELIS","REGN","LLII","LLY"],"isVideo":true,"video":{"duration":206,"video_url":"https://news-video-sg.skytigris.cn/videos/cdn/3081.mp4","video_thumbnail":"https://news-video-sg.skytigris.cn/videos/covers/3081.webp","audio_url":"https://static.tigerbbs.com/f1bbc2b54742b92aafc704bc4d0c576c.mp3","isAI":true},"gpt_icon":0},{"id":"1198460816","title":"23.3% Vs 14.8%: Lilly's New Data Just Changed The Obesity Drug Playbook","url":"https://stock-news.laohu8.com/highlight/detail?id=1198460816","media":"Bellwether Stocks Movement","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1198460816?lang=en_us&edition=fundamental","pubTime":"2026-10-03 16:06","pubTimestamp":1791014787,"startTime":"0","endTime":"0","summary":"","market":"uk","thumbnail":"https://news-video-sg.skytigris.cn/videos/covers/3076.webp","type":0,"news_type":0,"thumbnails":["https://news-video-sg.skytigris.cn/videos/covers/3076.webp"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"23.3% Vs 14.8%: Lilly's New Data Just Changed The Obesity Drug Playbook","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MRNX","NVO","JNJ","BMY","ELIL","ELIS","AMGN","BIIB","GSKH","SNY","ABT","VIR","NVOH","PFE","NVOX","ABBV","MRNY","NVS","VERU","LLYX","AZN","GILD","LLY","LLII","MRK","BNTX","NVOC","NVAX","REGN","MRNA","GSK"],"isVideo":true,"video":{"duration":261,"video_url":"https://news-video-sg.skytigris.cn/videos/cdn/3076.mp4","video_thumbnail":"https://news-video-sg.skytigris.cn/videos/covers/3076.webp","audio_url":"https://static.tigerbbs.com/5f9a45d52af3674e966786287f89b42c.mp3","isAI":true},"gpt_icon":0},{"id":"2672741768","title":"Novo Nordisk Says FDA Review of Hemophilia Drug is Hitting Delays","url":"https://stock-news.laohu8.com/highlight/detail?id=2672741768","media":"Dow Jones","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672741768?lang=en_us&edition=fundamental","pubTime":"2026-10-03 06:13","pubTimestamp":1790979180,"startTime":"0","endTime":"0","summary":"Novo Nordisk received notice from the Food and Drug Administration that its review of denecimig for the treatment of hemophilia A is still ongoing.The FDA hasn't communicated a new timeline for expected regulatory action on the biologics license application, the drug company said Friday.The cause for the extension of the agency's review is ongoing remediation activities at Novo's manufacturing facility. The FDA performed a pre-license inspection of the site and provided feedback after the company first submitted its license application.Novo submitted the application to the FDA in September 2025 for denecimig as a treatment of hemophilia A in adult and pediatric patients. At that time, it was anticipating a regulatory decision in the third quarter of 2026.The FDA hasn't identified deficiencies related to the clinical efficacy or safety data of the drug, Novo said. The company is continuing implementation of the facility remediation activities in response to the FDA's feedback.The prolon","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PPH","BK4532","NVO","BK4588","NVOX","IE00BZ1G4Q59.USD","LU1093756168.USD","OZEM","BK4599","BK4007","LU0154236417.USD","BK4585","THNR","NVOC","LU1093756325.SGD","IE00BKVL7J92.USD","NVOH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672743136","title":"Novo Nordisk Tests Zenagamtide Dosing to Sharpen Its Obesity Drug Pipeline","url":"https://stock-news.laohu8.com/highlight/detail?id=2672743136","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672743136?lang=en_us&edition=fundamental","pubTime":"2026-10-03 00:31","pubTimestamp":1790958671,"startTime":"0","endTime":"0","summary":"Novo Nordisk ($NVO) announced an update on their ongoing clinical study. The study Investigating the Effect of Post-dose Meal Timings and Water Vol...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/novo-nordisk-tests-zenagamtide-dosing-to-sharpen-its-obesity-drug-pipeline?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/novo-nordisk-tests-zenagamtide-dosing-to-sharpen-its-obesity-drug-pipeline?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0154236417.USD","NVOH","PPH","THNR","IE00BKVL7J92.USD","NVOX","BK4532","BK4585","BK4599","LU1093756168.USD","IE00BZ1G4Q59.USD","NVO","BK4588","OZEM","NVOC","BK4007","LU1093756325.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672574802","title":"Novo Nordisk A/S Series B Stock Falls Friday, Underperforms Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2672574802","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672574802?lang=en_us&edition=fundamental","pubTime":"2026-10-03 00:03","pubTimestamp":1790956980,"startTime":"0","endTime":"0","summary":"This article was automatically generated using Dow Jones technology.Shares of Novo Nordisk A/S Series B shed 0.5% to DKK248.75 Friday on what proved to be an overall positive trading session for the stock market, with the OMX Nordic 40 Index rising 1.1% to 2,596.93.This was the stock's second consecutive day of losses.The company closed DKK161.20 short of its 52-week high of DKK409.95, which the company achieved on January 23, 2026.Trading volume was 4,305,929, compared to the 50-day average trading volume of 4,898,141.Data source: Dow Jones Market Data, FactSet","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK4588","NVO","NVOC","NVOH","LU1093756325.SGD","NVOX","BK4599","OZEM","LU1093756168.USD","PPH","IE00BKVL7J92.USD","LU0154236417.USD","IE00BZ1G4Q59.USD","THNR","BK4532","BK4007"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":1,"totalSize":200,"code":"91000000","status":"200"}]}}